SCHEMBL2784397

SCHEMBL2784397

Nc1cc2cc3c(C(O)(C(F)(F)F)C(F)(F)F)c(N)ccc3cc2cc1C(O)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 1/20 0.41
GLA P06280 1/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
ATM Q13315 1/20 0.41
HSD17B10 Q99714 1/20 0.41
LMNA P02545 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KCNJ11 Q14654 2/20 0.35
ABCC9 O60706 1/20 0.31
ABCC8 Q09428 1/20 0.31
KCNJ8 Q15842 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2782858 1.00 SMN1; SMN2 (0.46) SMN1; SMN2KDM4EMEN1MAPTKMT2A
SCHEMBL2785175 0.92 SMN1; SMN2 (0.50) SMN1; SMN2KDM4EMEN1MAPTKMT2A
SCHEMBL2782861 0.92 SMN1; SMN2 (0.50) SMN1; SMN2KDM4EMEN1MAPTKMT2A
SCHEMBL2783950 0.91 SMN1; SMN2 (0.42) SMN1; SMN2KDM4EMEN1MAPTKMT2A
SCHEMBL2784728 0.91 SMN1; SMN2 (0.42) SMN1; SMN2KDM4EMEN1MAPTKMT2A
SCHEMBL2783869 0.91 SMN1; SMN2 (0.42) SMN1; SMN2KDM4EMEN1MAPTKMT2A
SCHEMBL2784474 0.87 SMN1; SMN2 (0.44) SMN1; SMN2KDM4EMEN1MAPTKMT2A
SCHEMBL2786121 0.86 SMN1; SMN2 (0.43) SMN1; SMN2KDM4EMEN1MAPTKMT2A
SCHEMBL2782385 0.85 KDM4E (0.45) SMN1; SMN2KDM4EMEN1MAPTKMT2A
SCHEMBL2783349 0.85 SMN1; SMN2 (0.46) SMN1; SMN2KDM4EMEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130085237-A1 Fluorinated Diamine and Polymer Formed Therefrom CENTRAL GLASS COMPANY, LIMITED (JP) 2013-04-04 US disclosed
US-20100029895-A1 Fluorinated Diamine and Polymer Formed Therefrom CENTRAL GLASS COMPANY, LIMITED (JP) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029895-A1 Fluorinated Diamine and Polymer Formed Therefrom AFF2, AFF1, AFF4 SMN1; SMN2 3673/4885KDM4E 1841/4885MEN1 2546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.